Model variablea | Beta | P value | Model fit (R2) | Target trough achievement (95% CI) |
---|---|---|---|---|
Model 1: log creatinine | Â | Â | 0.306 | 35% (28%-42%) |
  Intercept | 9.10 | 0.002 |  | |
  Age, years | 0.0886 | 0.002 | ||
  Male | −2.30 | 0.02 | ||
  Weight, kg | −0.0136 | 0.004 | ||
  Vancomycin total dose, g | 3.28 | <0.001 | ||
  Every 8-hour interval | 3.18 | 0.1 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −6.61 | <0.001 | ||
  Log baseline creatinine | 8.80 | <0.001 | ||
Model 2: log cystatin C | Â | Â | 0.559 | 52% (45%-59%) |
  Intercept | 10.2 | <0.001 |  | |
  Age, years | −0.00578 | 0.8 | ||
  Male | −2.32 | 0.004 | ||
  Weight, kg | −0.0708 | 0.05 | ||
  Vancomycin total dose, g | 2.50 | <0.001 | ||
  Every 8-hour interval | 4.25 | 0.009 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −6.66 | <0.001 | ||
  Log baseline cystatin C | 12.6 | <0.001 | ||
Model 3: log creatinine and log cystatin C | Â | Â | 0.575 | 53% (45%-60%) |
  Intercept | 11.5 | <0.001 |  | |
  Age, years | 0.00582 | 0.8 | ||
  Male | −2.64 | 0.001 | ||
  Weight, kg | −0.0931 | 0.01 | ||
  Vancomycin total dose, g | 2.70 | <0.001 | ||
  Every 8-hour interval | 4.15 | 0.009 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −7.90 | <0.001 | ||
  Log baseline creatinine | 2.89 | 0.01 | ||
  Log baseline cystatin C | 11.3 | <0.001 | ||
Model 4: eGFR with Cockcroft-Gault | Â | Â | 0.269 | 33% (26% - 40%) |
  Intercept | 10.3 | <0.001 |  | |
  Vancomycin total dose, g | 2.66 | <0.001 | ||
  Every 8-hour interval | 3.20 | 0.1 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −4.11 | 0.008 | ||
  eGFR with Cockcroft-Gault, mL/min | −0.0704 | <0.001 | ||
Model 5: eGFR with CKD-EPI creatinine | Â | Â | 0.394 | 38% (31%-46%) |
  Intercept | 16.4 | <0.001 |  | |
  Vancomycin total dose, g | 3.35 | <0.001 | ||
  Every 8-hour interval | 3.47 | 0.06 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −7.58 | <0.001 | ||
  eGFR with CKD-EPIcreatinine, mL/minb | −0.163 | <0.001 | ||
Model 6: eGFR with CKD-EPI cystatin C | Â | Â | 0.538 | 51% (44%-59%) |
  Intercept | 14.3 | <0.001 |  | |
  Vancomycin total dose, g | 2.61 | <0.001 | ||
  Every 8-hour interval | 4.91 | <0.001 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −5.94 | <0.001 | ||
  eGFR with CKD-EPIcystatin C, mL/minb | −0.134 | <0.001 | ||
Model 7: eGFR with CKD-EPI creatinine-cystatin C | Â | Â | 0.580 | 54% (45%-61%) |
  Intercept | 16.7 | <0.001 |  | |
  Vancomycin total dose, g | 2.95 | <0.001 | ||
  Every 8-hour interval | 4.84 | 0.002 | ||
  Every 12-hour interval | REF | - | ||
  Every 24-hour interval | −7.70 | <0.001 | ||
  eGFR with CKD-EPIcreatinine-cystatin C, mL/minb | −0.163 | <0.001 |